Clinical trial
Regression of Fatty Heart by Valsartan Therapy
NCT00745953 is registered in ClinicalTrials.gov with University of Texas Southwestern Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Regression of Fatty Heart by Valsartan Therapy
- Lead sponsor
- University of Texas Southwestern Medical Center
- Phase
- Phase 4
- Overall status
- Withdrawn
- Start date
- August 31, 2007
- Completion date
- August 31, 2009
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lipotoxicity, metabolic syndrome